33rd Annual Meeting & Pre-Conference Programs (SITC 2018)

Starts:  Nov 7, 2018 8:00 AM (ET)
Ends:  Nov 11, 2018 12:00 PM (ET)

SITC_2018_Logo_png.pngThe 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) scheduled to take place Nov. 7-11, 2018 at the Walter E. Washington Convention Center in Washington, D.C.

Visit the SITC 2018 website today!

Click here to download a PDF brochure about SITC 2018.

Dates to Remember

  • Registration and Housing open to SITC members: March 20, 2018
  • Registration and Housing open to all: April 3, 2018
  • Abstract submission site open: April 3, 2018
  • Abstract submission site close: Aug. 1, 2018
  • Late-Breaking Abstract submission site open: Aug. 24, 2018
  • Late-Breaking Abstract submission site close: Sept. 13, 2018
  • Early Registration ends: Oct. 10, 2018
  • Housing closes: Oct. 15, 2018

Thank You to Our Organizers!

Annual Program Committee

Chair: Mario Sznol, MD – Yale School of Medicine
Susan M. Kaech, PhD – Yale University
Laura S. Wood, RN, MSN, OCN – Cleveland Clinic Taussig Cancer Center

33rd Annual Meeting

Crystal L. Mackall, MD – Stanford University
Naiyer A. Rizvi, MD – Columbia University Medical Center
Krista M. Rubin, MS, FNP-BC – Massachusetts General Hospital
Dario A. A. Vignali, PhD – University of Pittsburgh

Workshop on Dietary Effects on the Microbiome

Laurence Zitvogel, MD, PhD – Institute Gustave Roussy

Primer on Tumor Immunology and Cancer Immunotherapy™

Timothy NJ Bullock, PhD – University of Virginia
Jonathan Powell, MD, PhD – Johns Hopkins University School of Medicine

Programming

Plenary Sessions

Cell-Based Therapies for Solid Tumors
Immune Checkpoints— Beyond PD 1
Next Generation Bispecifics and Antibody-Like Molecules
Understanding the Tumor Microenvironment

Concurrent Sessions

Advances in Immunotherapy in:

  • Pediatric Malignancies
  • Lung, Head and Neck Cancer
  • GI and Pancreatic Cancer
  • GU Tumors
  • Breast and Ovarian Cancers
  • Hematologic Malignancies

Basic Biology of Tregs
Clinical Management of Cell Therapy Administration
Clinical Trial Design/Surrogate Efficacy Markers
Cytokines Reinvented
Early Phase 1 Clinical Trials
Metabolic Manipulation of the TME
Myeloid Derived Suppressive Populations
Role of B cells in Immunotherapy Toxicity

Visit the SITC 2018 website to learn more.


#CME
#CNE
#CPE
#ClinicalTrials
#GenitourinaryCancers
#HeadandNeckCancers
#HematologicMalignancies
#LungCancers
#BreastCancers
#Advanced
#Foundational
#Intermediate
#InPersonEvent
#AnnualMeetingandPre-ConferencePrograms
#AlliedHealth
#Clinician
#Industry
#Nurse
#Oncologist
#PatientAdvocate
#Pharmacist
#PrimaryCarePhysician
#Researcher

Location

Walter E. Washington Convention Center
801 Mt Vernon Pl NW
Washington, D.C., DC 20001

Contact